Furthermore, RH-Δcps treatment had significant therapeutic effects on pancreatic tumor-bearing mice, as indicated by changes in IL-12 and IFN-γ production, MyD88 signaling, and CD8+ T-cell populations118. This evidence concerns the gene CD8A and pancreatic neoplasm.